5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example
    Journal Article

    Burotto, M.; Wilkerson, J.; Stein, W.; Motzer, R.; Bates, S.; Fojo, T.
    PLoS ONE (2014)

    Fulltext@MSK | Save
  • The role of high-dose chemotherapy in the management of germ cell tumors
    Journal Article

    Bastos, D. A.; Feldman, D. R.
    Current Opinion in Oncology (2014)

    Fulltext@MSK | Save
  • Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignancies
    Journal Article

    Abdel-Wahab, O.; Klimek, V. M.; Gaskell, A. A.; Viale, A.; Cheng, D.; Kim, E.; Rampal, R.; Bluth, M.; Harding, J. J.; Callahan, M. K.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • Sorbitol as a novel mechanism of hypoxia-inducible factor (HIF) pathway activation in clear cell papillary renal cell carcinoma (CCPRCC)
    Meeting Abstract

    Tickoo, S. K.; Hakimi, A. A.; Xu, J.; Lee, C. H.; Chen, Y. B.; Stirdivant, S.; Neri, B.; Wolfert, R.; Fine, S. W.; Al-Ahmadie, H.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Urothelial carcinoma with ERBB2 mutations: Molecular, immunohistochemical and morphologic analysis
    Meeting Abstract

    Ren, Q.; Kim, P. H.; Sfakianos, J. P.; Scott, S.; Iyer, G.; Hanrahan, A. J.; Tickoo, S. K.; Fine, S. W.; Gopalan, A.; Chen, Y. B.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Urothelial carcinoma with ERBB2 mutations: Molecular, immunohistochemical and morphologic analysis
    Meeting Abstract

    Ren, Q.; Kim, P. H.; Sfakianos, J. P.; Scott, S.; Iyer, G.; Hanrahan, A. J.; Tickoo, S. K.; Fine, S. W.; Gopalan, A.; Chen, Y. B.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Phase I/II study of paclitaxel plus ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Meeting Abstract

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of urothelial bladder carcinoma
    Journal Article

    The Cancer Genome Atlas Research Network
    Nature (2014)

    Fulltext@MSK | Save
  • Bone metastases in castration-resistant prostate cancer: Associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival
    Journal Article

    Vargas, H. A.; Wassberg, C.; Fox, J. J.; Wibmer, A.; Goldman, D. A.; Kuk, D.; Gonen, M.; Larson, S. M.; Morris, M. J.; Scher, H. I.; more...
    Radiology (2014)

    Fulltext@MSK | Save
  • Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial
    Journal Article

    Motzer, R. J.; Porta, C.; Vogelzang, N. J.; Sternberg, C. N.; Szczylik, C.; Zolnierek, J.; Kollmannsberger, C.; Rha, S. Y.; Bjarnason, G. A.; Melichar, B.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save